CMS Coverage-With-Evidence-Development Policy Could Face Revamp
This article was originally published in The Gray Sheet
CMS is taking comments through Jan. 6 on implementation of CED policies as part of national coverage determinations, how CED impacts Medicare beneficiaries and how new approaches might maximize benefits.
You may also be interested in...
Local Coverage With Evidence Development Is Legit, CMS Says; But It May Be Rare
CMS issued its final guidance on the coverage-with-evidence-development program, two years following a draft. It is explicit that local Medicare contractors can employ CED in setting coverage policies in their jurisdictions, but it is not clear that the language will encourage significant use at the local level. The guidance also revises its approach on ending CED policies compared to what was stated in the 2012 draft guidance.
CMS Ambiguous On Role Of Local Contractors In Coverage With Evidence Development
Activities by Medicare contractors were among several matters that were addressed in CMS’ recent CED draft guidance that may not be fully clarified until the updated guidelines are put into practice, experts say.
Washington Roundup, May 2012
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we report on the new Medicare coverage policy for transcatheter aortic valve replacement and Medicare latest hospital inpatient payment proposal.